Sentences with phrase «scientists studying their disease»

The researchers are starting to see matches among patients with the same rare disease, and between patients and scientists studying their disease.

Not exact matches

Hall's coral studies focus on the effects of heat, acidification, and disease, which help scientists find and breed particularly resilient candidates for replanting on reefs.

And Christian Scientists should up the ante in their war on medicine and make everyone know that everyone can cure disease like Jesus if they study study Mary Baker Eddy's book.

Sayers adds, «Scientists also did a study of Native American plains Indians and found that while some died of tuberculosis and other infectious diseases, they never found any evidence of cancer or heart or stroke problems.

They even fund research scientists at prestigious universities to conduct studies and write policy papers that are skewed toward saying that their products don't contribute to diabetes, heart disease, obesity etc..

Alexis is a scientist at a local research institute where she pursues the study of infectious diseases.

Forward - thinking scientists, many with funding from PETA and its international affiliates, are developing methods for studying diseases and testing products that don't require the use of animals and are actually relevant to human health.

A far - reaching study conducted by scientists at Cincinnati Children's reports that the Epstein - Barr virus (EBV)-- best known for causing mononucleosis — also increases the risks for some people of developing seven other major diseases.

But University of Illinois scientists recently published a new study that could help explain the movement of the disease across the landscape.

Scientists use cell reprogramming techniques to produce cells in the lab so that they can study diseases.

In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryo.

The low dose required for infectivity and the severity of the disease it causes had led the Centers for Disease Control and Prevention to classify F. tularensis as a Category A bioterrorism agent, and to track tularemia cases nationwide, according to Dr. Brook Peterson, a senior scientist at the UW School of Medicine who also participated in thedisease it causes had led the Centers for Disease Control and Prevention to classify F. tularensis as a Category A bioterrorism agent, and to track tularemia cases nationwide, according to Dr. Brook Peterson, a senior scientist at the UW School of Medicine who also participated in theDisease Control and Prevention to classify F. tularensis as a Category A bioterrorism agent, and to track tularemia cases nationwide, according to Dr. Brook Peterson, a senior scientist at the UW School of Medicine who also participated in the study.

Though this research focused on the form of the disease called Leber congenital amaurosis 2, or LCA2, the scientists and engineers involved in the study believe the technology holds promise for other forms of LCA as well as other inherited diseases that lead to severe vision loss or blindness.

Scientists have made a key discovery that could speed up the production of cells in the lab for studying diseases such as multiple sclerosis and Parkinson's disease.

In the now published study, scientists compared genomes of 42,335 people with coronary artery disease and 78,240 healthy people with 5,000 commonly occurring SNPs.

More broadly, she hopes to remind scientists studying brain disease that women's and men's brains, though equal in aptitude, are not the same.

Scientists have shifted from studying single molecules to investigating large complexes of interacting biological macromolecules involved in processes such as metabolic pathways, gene expression, and development of disease.

Scientists study VSV, which causes acute disease in livestock but typically does not lead to illness in people, as a model for viruses that are harmful to humans.

Kessler Foundation scientists collaborated with colleagues in Spain to study memory and learning in patients with Parkinson Disease (PD).

Perchlorate, a hazardous chemical in rocket fuel, has been found at potentially dangerous levels in powdered infant formula, according to a study (pdf) by a group of U.S. Centers for Disease Control scientists.

But a new study suggests that mature cells also play a key role in initiating cancer — a finding that could upend the way scientists think about the origins of the disease.

A new study provides what scientists say is the most convincing evidence to date that the Italian adventurer and some of his crew contracted the disease during their voyage to the New World — and unwittingly introduced it to the old one circa 1493.

These techniques include: human tissue created by reprogramming cells from people with the relevant disease (dubbed «patient in a dish»); «body on a chip» devices, where human tissue samples on a silicon chip are linked by a circulating blood substitute; many computer modelling approaches, such as virtual organs, virtual patients and virtual clinical trials; and microdosing studies, where tiny doses of drugs given to volunteers allow scientists to study their metabolism in humans, safely and with unsurpassed accuracy.

Then she moved to her current position as principal scientist of a group that studies Alzheimer's disease and age - related macular degeneration at San Francisco's Rinat Laboratories, which is owned by Pfizer.

To truly untangle the mystery of the disease, scientists must cultivate M. leprae for study.

Inspired by human studies showing that avid coffee drinkers and smokers have a lower risk of Parkinson's disease, scientists at the University of Washington decided to see what java and cigarettes do to fruit flies.

«This opens a new door in identifying biological markers for dementia since we might consider using the brain's processing of speech sounds as a new way to detect the disease earlier,» says Dr. Claude Alain, the study's senior author and senior scientist at Baycrest's Rotman Research Institute (RRI) and professor at the University of Toronto's psychology department.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

► In this week's Science Careers - produced «Working Life» column, researchers George F. Gao and Yong Feng «urge young scientists planning their careers to consider studying communicable diseases, especially highly pathogenic ones like Ebola or Lassa fever.»

So until recently, much of what scientists learned was gleaned by inference or from studying mouse models of the disease.

Scientists now have a base of knowledge they can use to more strategically and precisely study diseases and explore new treatments.

This mechanism may be involved in many more diseases,» explains study's co-author, Dr. David Rosenblatt, a scientist in the Child Health and Human Development Program at the RI - MUHC and holder of the Dodd Q. Chu and Family Chair in Medical Genetics in the Department of Human Genetics at McGill University.

In particular, the scientists studied comments and sentiments expressed about Alzheimer's disease and other forms of dementia.

Clinician - scientists worried that studying mouse cells wouldn't be truly reflective of human disease.

«We think this could provide a paradigm shift in the treatment of age - related disease, including cancer,» said Buck professor Judith Campisi, PhD, senior scientist on the study.

For now, scientists tend to focus their multi-omic studies on a particular disease or question.

Now, a team of scientists at the Icahn School of Medicine at Mount Sinai have developed the Just EGFP Death - Inducing T - cell, or JEDI T - cells, which enable the visualization of T - cell antigens, allowing researchers to study T - cell interactions with different cell types, model disease states, and finally determine the functions of otherwise poorly characterized cell populations.

The study authored by Forest Service Southern Research Station (SRS) scientists John Coulston, David Wear, and Jim Vose is the first to isolate the impacts of forest disturbances, such as fire, disease, and cutting, as well as the impacts of land use change using permanent monitoring locations across the Southeast making it one of the most thorough carbon studies completed.

Last week, scientists at Harvard University and Columbia University announced that they had proved the viability of a new way to study a disease — amyotrophic lateral sclerosis — by reprogramming cells from a patient to become pluripotent stem cells, which can then become any type of cell or tissue.

Because there's evidence that the words we hear and the words we recall or imagine trigger similar brain processes, the study, published online today in PLoS Biology, suggests scientists may one day be able to tune in to the words you're thinking — a potential boon for patients who are unable to speak due to Lou Gehrig's disease or other conditions.

A sleep deficiency of even a small degree can disrupt our lives in a number of ways — from a setback in daily routine to bringing about or exacerbating existing chronic diseases,» said Andrew N. Carr, Ph.D., Clinical Scientist and study co-author, Procter & Gamble.

Their dual training gives them a unique perspective: Well - trained physician - scientists have the experience and instincts to observe clinical syndromes, reflect on symptoms in the light of fundamental biological science, and pursue the study of those diseases through hypothesis - driven research.

The physician - scientist may study the same properties of the same molecule but for a different reason: because he or she believes that those studies will provide information on the fundamental pathology of a disease or insight into human biology that will provide a better understanding of healthy versus diseased states.

The study is expected to generate interest in the age research field among scientists studying rapamycin and its analogs as they look for ways to forestall late - life diseases.

«The specific macromolecular complex investigated in this study has therapeutic implications not only for addiction, but also for Parkinson's disease and schizophrenia,» said Dr. Sergi Ferré, who led the team of scientists.

«Through major genetics studies,» Borenstein noted, «scientists have made valuable progress in gathering information on the species composition of the human microbiome in health and disease.»

But translation is not one - way; the insights gained at the bedside, and from clinical and population - based studies, will spawn hypotheses, enabling scientists to probe the mechanisms of disease in new ways and ultimately enriching basic biology.

«By reprogramming human cells, scientists have created new opportunities to study diseases and develop methods for diagnosis and therapy,» the Nobel judges wrote.

Currently, more than 100 research scientists and postdoctoral fellows are performing basic studies in cardiovascular disease, HIV / AIDS, and neurodegenerative disorders.

Whilst established to examine possible safety issues with biologic therapies, it provides the opportunity to look at additional benefits beyond the direct effect on disease severity,» explains William Dixon, MD, MRC clinician scientist / senior clinical lecturer and honorary consultant rheumatologist; Arthritis Research UK Epidemiology Unit, The University of Manchester; and an investigator in the study.